Divided Infringement and Subject-Matter Eligibility: Are Mixed Diagnostic and Therapeutic Method Claims Viable and Valuable? By Sarah A. Kagan Until recently, diagnostic assay developers wanting to protect their innovations with
Subject-Matter Eligibility Swallows Infringement Litigation? By Lisa M. Hemmendinger and Sarah A. Kagan On October 4, 2017, the U.S. Court of Appeals for the Federal Circuit heard oral arguments in
Banner & Witcoff was recognized by Law360 for its role in client YETI Coolers LLC’s lawsuit against Costco Wholesale Corp. for infringing its trademarks and design patents by selling unlicensed knockoffs of
Anna L. King and Luke S. Curran discuss why registration of sound marks is a key business strategy and will become more frequent at the U.S. Patent and Trademark Office in their article, “The Hidden Persuader:
Banner & Witcoff attorney Robert H. Resis was recognized by Law360 for his role in drafting the Intellectual Property Law Association of Chicago amicus brief “calling for the full Federal Circuit to review its panel
Obviousness: The Analytic Framework May Control the Outcome By Sarah A. Kagan Some aspects of the law of obviousness seem hard to apply, as they are repeatedly challenged on appeals
Venue Okay in Cray? Federal Circuit Says “No Way” Federal Circuit Interprets Patent Venue Statute Post TC Heartland By Jeffrey H. Chang Ever since the Supreme Court held in
Scott M. Kelly comments on issues facing the 5-year-old Patent Trial and Appeal Board in, “Apple Likes the Patent ‘Death Squad.’ Allergan Pays to Avoid It,” in Bloomberg Technology. Click here to read the
Clinical Trials: When is the Right Time to File for a Patent? By Sarah A. Kagan Not uncommonly, clinical investigators ask, “When is the right time to file a
Husky Injection Molding Systems, a long-time Banner & Witcoff client, received a 2017 Legal Department Award at the Canadian Lawyer InHouse Innovatio Gala Dinner and Awards Presentation on Sept. 19 in
